Search results for "ffpe challenges"

Collaborations with the UK government and wider academic community have driven innovation to quickly meet COVID demands

Chromium Single Cell Gene Expression Flex empowers your research in remarkable new ways, enabling you to take scRNA-seq further than it’s ever gone before. This advanced chemistry provides 10x Genomics' most sensitive whole transcriptome profiling with the ultimate flexibility to meet your experimental needs every step of the way.

This transaction will expand BioIVT’s biospecimen collection network by approximately 150 sites in the US, UK, and Europe and broaden its offerings for drug and diagnostic developers

Dr. Ofer Sharon discusses a new cancer research platform designed to improve patient outcomes, cut costs, and minimize unnecessary adverse events

One test that can expedite NSCLC treatment selection decisions. The Oncomine Dx Target Test is the first targeted NGS-based in vitro diagnostic test for NSCLC, simultaneously delivering multiple biomarker results from one sample within four days and helping inform treatment decisions.

Find out about the 'revolutionary' technology enabling one lab to provide higher-quality, more timely data for cancer researchers

Watch this on-demand webinar to find out the advantages of immunotyping over immunofixation in detecting M-proteins

Discover how a laboratory in the US is harnessing extrusion- and light-based bioprinters to generate complex, anatomically accurate tissue models

Global provider of gene editing and personalized medicine technologies has launched a service for high-throughput gene expression analysis

Sample preparation solutions for unique applications and difficult samples

DNA polymerase included, Complete Kit with optimized enzyme to amplify total RNA in <4 hours, no 3′ bias

Qualitative detection of 15 High-Risk HPV types with simultaneous genotyping of HPV16 and 18 in one tube. Fast. Simple. Accurate.

Qualitative detection and identification of 15 High-Risk HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, and 68. Fast. Simple. Accurate.

New proprietary assembly technology pairs with groundbreaking complex DNA synthesis platform to deliver sequence-perfect clonal DNA as long as 5 kb

The innovative instrument helps clinical flow cytometry labs automate end-to-end sample preparation

New centrifuge options accommodate speeds up to 110,000 x g and capacities up to six liters

The VENTANA MMR RxDx Panel is the first and only immunohistochemistry-based assay approved to identify endometrial carcinoma patients eligible for treatment with JEMPERLI (dostarlimab).